Cited by 80Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesPrenatal Substance Exposure Effects

Extended treatment with bupropion SR for cigarette smoking cessation

Killen, Joel D., Fortmann, Stephen P., Murphy, Greer M., Hayward, Chris, Arredondo, Christina, Cromp, DeAnn, Celio, Maria, Abe, Laurie +2 more·2006·Journal of Consulting and Clinical Psychology

Abstract

The authors present results of a randomized clinical trial of the efficacy of extended treatment with bupropion SR in producing longer term cigarette smoking cessation. Adult smokers (N = 362) received open-label treatment (11 weeks) that combined relapse prevention training, bupropion SR, and nicotine patch followed by extended treatment (14 weeks) with bupropion SR or matching placebo. Abstinence percentages were relatively high (week 11: 52%; week 25: bupropion, 42%; placebo, 38%; week 52: bupropion, 33%; placebo, 34%), but bupropion SR did not surpass placebo. Gender and baseline craving level were identified as significant, independent moderators of treatment response. Men were more likely to abstain than women (week 11: 59% vs. 43%, p = .001; week 25: 48% vs. 31%, p = .001; week 52: 39% vs. 27%, p = .01). Because most smokers suffer relapse with any current cessation treatment, the comparatively high abstinence percentages achieved in this trial are of interest.

Integrity signals

Registry

Crossref · 10.1037/0022-006x.74.2.286

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • No differences were observed between bupropion versus placebo both during and after relapse prevention intervention in other studies.

    “In other studies, no differences were observed between bupropion versus placebo both during and after relapse prevention intervention (117, 118).”

    From Tobacco addiction (2008) · cites this paper as [117]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Killen, J. D., Fortmann, S. P., Murphy, G. M., Hayward, C., Arredondo, C., Cromp, D., Celio, M., Abe, L., Wang, Y., & Schatzberg, A. F.
Affiliations
Stanford Medicine (US)
Venue
Journal of Consulting and Clinical Psychology
Published
2006
Volume
74
Issue
2
Pages
286-294
ISSN
  • 0022-006X (ISSN-L)
  • 1939-2117
OpenAlex
W1994470828
Cited by
80
References
53
Citations by year
2025: 1 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 2 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 1 · 2013: 6 · 2012: 7
FWCI
6.85
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Consulting and Clinical Psychology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (CA 090300)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
bupropion sustained release, smoking cessation, extended treatment, relapse prevention training, nicotine patch, smoking abstinence, gender differences, treatment moderators, nicotine dependence
MeSH terms
Adolescent, Adult, Aged, Delayed-Action Preparations, Female, Humans, Male, Middle Aged, Smoking, Smoking Cessation, Bupropion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review